Poliothrysoside and its derivatives as novel insulin sensitizers potentially driving AMPK activation and inhibiting adipogenesis

Show simple item record

dc.contributor.author Sashidhara, K V
dc.contributor.author Singh, S P
dc.contributor.author Varshney, Salil
dc.contributor.author Beg, Muheeb
dc.contributor.author Gaikwad, A N
dc.date.accessioned 2017-05-30T07:37:21Z
dc.date.available 2017-05-30T07:37:21Z
dc.date.issued 2014
dc.identifier.citation European Journal of Medicinal Chemistry, 2014, 86, 570-7 en
dc.identifier.uri http://hdl.handle.net/123456789/1692
dc.description.abstract In our efforts to develop safe and active chemical entities from nature, we first identified poliothrysoside (1), a phytoconstituent isolated from Flacourtia indica, possessing antidiabetic potential. Subsequently, fifteen derivatives (2-16) were synthesized to assess the activity profile of this class. All the compounds were analyzed for their glucose uptake potency in chronic insulin-induced insulin resistant 3T3-L1 adipocytes. Interestingly, compound 2 exhibited strong ability to increase the insulin sensitivity, primarily activating the AMPK signaling pathway and also inhibited the adipogenesis in 3T3-L1 adipocytes, in concentration dependent manner. Overall, these studies suggest the potential of poliothrysoside and its derivatives as promising leads for non-insulin dependent type 2 diabetes (T2D). en
dc.format.extent 493855 bytes
dc.format.mimetype application/pdf
dc.language.iso en en
dc.relation.ispartofseries CSIR-CDRI communication no. 8757. en
dc.subject Poliothrysoside en
dc.subject Insulin resistance en
dc.subject 3T3-L1 adipocytes en
dc.subject AMPK en
dc.subject Non-insulin dependent type 2 diabetes en
dc.title Poliothrysoside and its derivatives as novel insulin sensitizers potentially driving AMPK activation and inhibiting adipogenesis en
dc.type Article en


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account